ADAP Stock Price - ADAPTIMMUNE THERAPEUTICS-ADR Stock Price, News and Overview

Q: What is the stock price of ADAPTIMMUNE THERAPEUTICS-ADR today?

The current stock price of ADAP is 0.0799 USD . The price decreased by -0.5% in the last trading session.

Q: What is the ticker symbol for ADAPTIMMUNE THERAPEUTICS-ADR stock?

The exchange symbol of ADAPTIMMUNE THERAPEUTICS-ADR is ADAP and it is listed on the Nasdaq exchange.

Q: On which exchange is ADAP stock listed?

ADAP stock is listed on the Nasdaq exchange.

Q: What is the price forecast or stock price prediction for ADAPTIMMUNE THERAPEUTICS-ADR stock?

14 analysts have analysed ADAP and the average price target is 1.47 USD . This implies a price increase of 1743.79% is expected in the next year compared to the current price of 0.0799 . Check the ADAPTIMMUNE THERAPEUTICS-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

Q: How many employees does ADAPTIMMUNE THERAPEUTICS-ADR have?

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) currently has 506 employees.

Question 1

What is the stock price of ADAPTIMMUNE THERAPEUTICS-ADR today?

Accepted Answer

The current stock price of ADAP is 0.0799 USD. The price decreased by -0.5% in the last trading session.

Question 2

What is the ticker symbol for ADAPTIMMUNE THERAPEUTICS-ADR stock?

Accepted Answer

The exchange symbol of ADAPTIMMUNE THERAPEUTICS-ADR is ADAP and it is listed on the Nasdaq exchange.

Question 3

On which exchange is ADAP stock listed?

Accepted Answer

ADAP stock is listed on the Nasdaq exchange.

Question 4

What is the price forecast or stock price prediction for ADAPTIMMUNE THERAPEUTICS-ADR stock?

Accepted Answer

14 analysts have analysed ADAP and the average price target is 1.47 USD. This implies a price increase of 1743.79% is expected in the next year compared to the current price of 0.0799. Check the ADAPTIMMUNE THERAPEUTICS-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

Question 5

What is ADAPTIMMUNE THERAPEUTICS-ADR worth?

Accepted Answer

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) has a market capitalization of 21.18M USD. This makes ADAP a Nano Cap stock.

Question 6

How many employees does ADAPTIMMUNE THERAPEUTICS-ADR have?

Accepted Answer

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) currently has 506 employees.

Question 7

Is ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) expected to grow?

Accepted Answer

The Revenue of ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is expected to decline by -72.08% in the next year. Check the estimates tab for more information on the ADAP EPS, Sales, EBIT and EBITDA future analyst estimates.

Question 8

Should I buy ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) stock?

Accepted Answer

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

The Technical Analysis (TA) tab contains a technical analysis of ADAP, looking at technical quality and support and resistance levels
The Fundamental Analysis (FA) tab contains a fundamental analysis of ADAP, evaluating the profitability, health, valuation and growth aspects
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Sales and EPS estimates to see what analysts future expectations are.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Insider and Institutional Ownership to learn about the owners and their transactions.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Chart to make your own analysis
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Latest news and press-releases to stay up to date.

Question 9

Does ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) stock pay dividends?

Accepted Answer

ADAP does not pay a dividend.

Question 10

When does ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) report earnings?

Accepted Answer

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) will report earnings on 2025-08-11, before the market open.

Question 11

What is the Price/Earnings (PE) ratio of ADAPTIMMUNE THERAPEUTICS-ADR (ADAP)?

Accepted Answer

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.2).

Question 12

What is the Short Interest ratio of ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) stock?

Accepted Answer

The outstanding short interest for ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is 8.85% of its float. Check the ownership tab for more information on the ADAP short interest.

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Price, Quote, News and Overview